GH35 Tablets for Advanced Solid Tumors: A Study on Safety and Early Results

NCT05010694 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Advanced Solid Tumors Harboring With G12C Mutation

Interventions

DRUG: GH35 Tablet

Sponsor

Suzhou Genhouse Bio Co., Ltd.